Retinoic acid in the immune system

Annals of the New York Academy of Sciences

Volumn 1143, Issue , 2008, Pages 170-187

  Pino Lagos, Karina ^a   Benson, Micah J ^a   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Immune system; Retinoic acid; Tolerance; Vitamin A

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CELLULAR RETINOL BINDING PROTEIN; FENRETINIDE; INTERLEUKIN 12; NITRIC OXIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; RETINOL; RETINOL BINDING PROTEIN; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; AUTOIMMUNITY; B LYMPHOCYTE; BINDING AFFINITY; BIOSYNTHESIS; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CLINICAL TRIAL; COLITIS; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; INFECTION; MACROPHAGE; MONOCYTE; NONHUMAN; ONTOGENY; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETINOL DEFICIENCY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSPORT KINETICS;

EID: 56749105755     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1443.017     Document Type: Review

References (118)

1. Duester, G. 2000. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267 : 4315 4324.
2. Smith, S.M. & C.E. Hayes. 1987. Contrasting impairments in IgM and IgG responses of vitamin A-deficient mice. Proc. Natl. Acad. Sci. USA 84 : 5878 5882.
3. Molotkov, A. et al. 2002. Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice. J. Biol. Chem. 277 : 13804 13811.
4. Molotkov, A. et al. 2002. Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proc. Natl. Acad. Sci. USA 99 : 5337 5342.
5. Molotkov, A., X. Fan & G. Duester. 2002. Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. Eur. J. Biochem. 269 : 2607 2612.
6. Napoli, J.L. 1999. Retinoic acid: its biosynthesis and metabolism. Prog. Nucleic Acid Res. Mol. Biol. 63 : 139 188.
7. Vasiliou, V. et al. 1999. Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Pharmacogenetics 9 : 421 434.
8. Vasiliou, V. et al. 1999. Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression. Pharmacogenetics 9 : 569 580.
9. Haselbeck, R.J. & G. Duester. 1997. Regional restriction of alcohol/retinol dehydrogenases along the mouse gastrointestinal epithelium. Alcohol Clin. Exp. Res. 21 : 1484 1490.
10. Fan, X. et al. 2003. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell Biol. 23 : 4637 4648.
11. Niederreither, K. et al. 2003. The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system. Development 130 : 2525 2534.
12. Mic, F.A. et al. 2002. Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 129 : 2271 2282.
13. Dupe, V. et al. 2003. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. USA 100 : 14036 14041.
14. Noy, N. 2000. Retinoid-binding proteins: mediators of retinoid action. Biochem. J. 348 (Pt 3 481 495.
15. Quadro, L. et al. 1999. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 18 : 4633 4644.
16. Levin, M.S. et al. 1987. Comparison of the tissue-specific expression and developmental regulation of two closely linked rodent genes encoding cytosolic retinol-binding proteins. J. Biol. Chem. 262 : 7118 7124.
17. Yost, R.W., E.H. Harrison & A.C. Ross. 1988. Esterification by rat liver microsomes of retinol bound to cellular retinol-binding protein. J. Biol. Chem. 263 : 18693 18701.
18. E, X. et al. 2002. Increased neonatal mortality in mice lacking cellular retinol-binding protein II. J. Biol. Chem. 277 : 36617 36623.
19. Dong, D. et al. 1999. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 274 : 23695 23698.
20. Soprano, D.R., P. Qin & K.J. Soprano. 2004. Retinoic acid receptors and cancers. Annu. Rev. Nutr. 24 : 201 221.
21. Mark, M., N.B. Ghyselinck & P. Chambon. 2006. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46 : 451 480.
22. Lufkin, T. et al. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. USA 90 : 7225 7229.
23. Lohnes, D. et al. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73 : 643 658.
24. Yang, L., A. Naltner & C. Yan. 2003. Overexpression of dominant negative retinoic acid receptor alpha causes alveolar abnormality in transgenic neonatal lungs. Endocrinology 144 : 3004 3011.
25. Kupumbati, T.S. et al. 2006. Dominant negative retinoic acid receptor initiates tumor formation in mice. Mol. Cancer 5 : 12.
26. Gao, P. et al. 2003. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J. Leukoc. Biol. 73 : 273 280.
27. Cobbold, S.P. et al. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213 : 239 255.
28. Mangelsdorf, D.J. & R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83 : 841 850.
29. Du, X. et al. 2005. An essential role for Rxr alpha in the development of Th2 responses. Eur. J. Immunol. 35 : 3414 3423.
30. Stephensen, C.B., A.D. Borowsky & K.C. Lloyd. 2007. Disruption of Rxra gene in thymocytes and T lymphocytes modestly alters lymphocyte frequencies, proliferation, survival and T helper type 1/type 2 balance. Immunology 121 : 484 498.
31. Semba, R.D. 1994. Vitamin A, immunity, and infection. Clin. Infect. Dis. 19 : 489 499.
32. Sherry, B. & A. Cerami. 1988. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J. Cell Biol. 107 : 1269 1277.
33. Mehta, K. et al. 1994. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J. Leukoc. Biol. 55 : 336 342.
34. Kang, B.Y. et al. 2000. Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells. Br. J. Pharmacol. 130 : 581 586.
35. Kim, B.H., K.S. Kang & Y.S. Lee. 2004. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells. Toxicol. Lett. 150 : 191 201.
36. Kang, S.G. et al. 2007. Vitamin a metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179 : 3724 3733.
37. Banchereau, J. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 : 767 811.
38. Geissmann, F. et al. 2003. Retinoids regulate survival and antigen presentation by immature dendritic cells. J. Exp. Med. 198 : 623 634.
39. Mohty, M. et al. 2003. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Br. J. Haematol. 122 : 829 836.
40. Saurer, L., K.C. McCullough & A. Summerfield. 2007. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J. Immunol. 179 : 3504 3514.
41. Iwata, M. et al. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 : 527 538.
42. Mora, J.R. et al. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 : 88 93.
43. Taraboletti, G. et al. 1997. Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. Int. J. Cancer 70 : 72 77.
44. Darmanin, S. et al. 2007. All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors. J. Immunol. 179 : 4616 4625.
45. Melani, C. et al. 2003. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102 : 2138 2145.
46. Bronte, V. et al. 2001. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. (1997). 24 : 431 446.
47. Carman, J.A. & C.E. Hayes. 1991. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J. Immunol. 147 : 1247 1252.
48. Ballow, M. et al. 1996. The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6. J. Clin. Immunol. 16 : 171 179.
49. Morikawa, K. & M. Nonaka. 2005. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 5 : 1830 1838.
50. Villamor, E. & W.W. Fawzi. 2005. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin. Microbiol. Rev. 18 : 446 464.
51. Szondy, Z. et al. 1998. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha. Biochem. J. 331 (Pt 3 767 774.
52. Zhou, X., W. Wang & Y. Yang. 2008. The expression of retinoic acid receptors in thymus of young children and the effect of all-transretinoic acid on the development of T cells in thymus. J. Clin. Immunol. 28 : 85 91.
53. Kiss, I. et al. 2008. Retinoid receptor-activating ligands are produced within the mouse thymus during postnatal development. Eur. J. Immunol. 38 : 147 155.
54. Smith, S.M., N.S. Levy & C.E. Hayes. 1987. Impaired immunity in vitamin A-deficient mice. J. Nutr. 117 : 857 865.
55. Carman, J.A., S.M. Smith & C.E. Hayes. 1989. Characterization of a helper T lymphocyte defect in vitamin A-deficient mice. J. Immunol. 142 : 388 393.
56. Cantorna, M.T., F.E. Nashold & C.E. Hayes. 1994. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152 : 1515 1522.
57. Stephensen, C.B. et al. 2002. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J. Immunol. 168 : 4495 4503.
58. Dawson, H.D. et al. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7 : 27.
59. Furuzawa-Carballeda, J., M.I. Vargas-Rojas & A.R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6 : 169 175.
60. Veldhoen, M. et al. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 : 179 189.
61. Ivanov, II. et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 : 1121 1133.
62. Mucida, D. et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 : 256 260.
63. Mora, J.R. et al. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314 : 1157 1160.
64. Jordan, M.S. et al. 2001. Thymic selection of CD4+CD25 +regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2 : 301 306.
65. Takahashi, T. & S. Sakaguchi. 2003. The role of regulatory T cells in controlling immunologic self-tolerance. Int. Rev. Cytol. 225 : 1 32.
66. Itoh, M. et al. 1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 : 5317 5326.
67. Takahashi, T. et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192 : 303 310.
68. Kumanogoh, A. et al. 2001. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J. Immunol. 166 : 353 360.
69. Shimizu, J. et al. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 : 135 142.
70. Kanamaru, F. et al. 2004. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J. Immunol. 172 : 7306 7314.
71. Hori, S., T. Takahashi & S. Sakaguchi. 2003. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81 : 331 371.
72. Takahashi, T. & S. Sakaguchi. 2003. Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease. Curr. Mol. Med. 3 : 693 706.
73. Sakaguchi, S. et al. 2003. Thymic generation and selection of CD25+CD4+ regulatory T cells: implications of their broad repertoire and high self-reactivity for the maintenance of immunological self-tolerance. Novartis Found Symp. 252 : 6 16 discussion 16-23, 106-114.
74. Hara, M. et al. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166 : 3789 3796.
75. van Maurik, A. et al. 2004. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. J. Immunol. 172 : 2163 2170.
76. Waldmann, H. et al. 2004. Regulatory T cells and organ transplantation. Semin Immunol. 16 : 119 126.
77. Lin, C.Y. et al. 2002. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat. Immunol. 3 : 1208 1213.
78. Graca, L. et al. 2000. Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165 : 4783 4786.
79. Taylor, P.A. et al. 2001. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40 L) monoclonal antibody under nonmyeloablative conditions. Blood 98 : 467 474.
80. Mayer, L. et al. 1986. Evidence for a defect in switch T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N. Engl. J. Med. 314 : 409 413.
81. Brunkow, M.E. et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 : 68 73.
82. Hori, S., T. Nomura & S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 : 1057 1061.
83. Fontenot, J.D., M.A. Gavin & A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25 +regulatory T cells. Nat. Immunol. 4 : 330 336.
84. Khattri, R. et al. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 : 337 342.
85. Fontenot, J.D. et al. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 : 329 341.
86. Wan, Y.Y. & R.A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102 : 5126 5131.
87. Chen, Y. et al. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 : 1237 1240.
88. Walker, L.S. et al. 2003. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198 : 249 258.
89. Zheng, S.G. et al. 2004. Natural and induced CD4+CD25 +cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172 : 5213 5221.
90. Zheng, S.G. et al. 2004. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172 : 1531 1539.
91. Horwitz, D.A., S.G. Zheng & J.D. Gray. 2003. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J. Leukoc. Biol. 74 : 471 478.
92. Jonuleit, H. et al. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192 : 1213 1222.
93. Sato, K. et al. 2003. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101 : 3581 3589.
94. Hoyne, G.F. et al. 2001. Notch signalling in the regulation of peripheral immunity. Immunol. Rev. 182 : 215 227.
95. Apostolou, I. et al. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3 : 756 763.
96. Benson, M.J. et al. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 : 1765 1774.
97. Coombes, J.L. et al. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-{beta) and retinoic acid dependent mechanism. J. Exp. Med. 204 : 1757 1764.
98. Schambach, F. et al. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37 : 2396 2399.
99. Sun, C.M. et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 : 1775 1785.
100. Bendich, A. 1992. Vitamins and immunity. J. Nutr. 122 : 601 603.
101. Semba, R.D. 1999. Vitamin A as "anti-infective" therapy, 1920-1940. J. Nutr. 129 : 783 791.
102. Bang, B.G., M.A. Foard & F.B. Bang. 1973. The effect of vitamin A deficiency and Newcastle disease on lymphoid cell systems in chickens. Proc. Soc. Exp. Biol. Med. 143 : 1140 1146.
103. Krishnan, S. et al. 1976. Effect of vitamin A and undernutrition on the susceptibility of rodents to a malarial parasite Plasmodium berghei. J. Nutr. 106 : 784 791.
104. West, C.E. et al. 1991. Vitamin A and immune function. Proc. Nutr. Soc. 50 : 251 262.
105. Wiedermann, U. et al. 1996. Vitamin A deficiency increases inflammatory responses. Scand. J. Immunol. 44 : 578 584.
106. Nauss, K.M. et al. 1985. Ocular infection with herpes simplex virus (HSV-1) in vitamin A-deficient and control rats. J. Nutr. 115 : 1300 1315.
107. Glick, A.B. et al. 1989. Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1 : 87 97.
108. Glick, A.B. et al. 1991. Complex regulation of TGF beta expression by retinoic acid in the vitamin A-deficient rat. Development 111 : 1081 1086.
109. Wakefield, L. et al. 1990. Regulation of transforming growth factor-beta subtypes by members of the steroid hormone superfamily. J. Cell Sci. Suppl. 13 : 139 148.
110. Racke, M.K. et al. 1995. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154 : 450 458.
111. Lovett-Racke, A.E. & M.K. Racke. 2002. Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cell Immunol. 215 : 54 60.
112. Qu, Z.X. et al. 1998. All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch. Neurol. 55 : 315 321.
113. Xu, J. & P.D. Drew. 2006. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 171 : 135 144.
114. Gershwin, M.E. et al. 1984. Nutritional factors and autoimmunity. IV. Dietary vitamin A deprivation induces a selective increase in IgM autoantibodies and hypergammaglobulinemia in New Zealand Black mice. J. Immunol. 133 : 222 226.
115. Kinoshita, K. et al. 2003. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J. Immunol. 170 : 5793 5798.
116. Perez de Lema, G. et al. 2004. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int. 66 : 1018 1028.
117. Nozaki, Y. et al. 2006. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin. Immunol. 119 : 272 279.
118. Klopcic, B. et al. 2008. Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: A role for SPARC. Dig. Dis. Sci. 53 : 1553 1563.